CyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsPhosphoramide MustardsVincristineDoxorubicinAntineoplastic Agents, AlkylatingPrednisoneImmunosuppressive AgentsMethotrexatePulse Therapy, DrugDrug Administration ScheduleEtoposideEpirubicinCombined Modality TherapyBusulfanThiotepaTreatment OutcomePrednisoloneBreast NeoplasmsRemission InductionAntibodies, Monoclonal, Murine-DerivedFluorouracilLeukopeniaVidarabineBone Marrow TransplantationGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinDisease-Free SurvivalTransplantation, AutologousMethylprednisoloneCystitisAdministration, MetronomicWhole-Body IrradiationHematopoietic Stem Cell TransplantationChemotherapy, AdjuvantDose-Response Relationship, DrugDrug Therapy, CombinationSurvival AnalysisCarmustineTransplantation ConditioningSurvival RateMelphalanImmunosuppressionAzathioprineWegener GranulomatosisLupus NephritisMesnaIfosfamideCisplatinTime FactorsAntineoplastic AgentsNeutropeniaChlorambucilAcroleinMitoxantroneFollow-Up StudiesRecurrenceBleomycinTransplantation, HomologousAlkylating AgentsHematopoietic Stem Cell MobilizationLeukocyte CountProcarbazineAnemia, AplasticDexamethasoneCytarabinePaclitaxelLymphoma, Large B-Cell, DiffuseAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisCarboplatinNeoplasm StagingInfusions, IntravenousLeukemia, Lymphocytic, Chronic, B-CellPrognosisGraft vs Host DiseaseMicroscopic PolyangiitisBone MarrowSpleenThrombocytopeniaAntibodies, MonoclonalVomitingMultiple MyelomaAdministration, OralNeoadjuvant TherapyProspective StudiesDrug EvaluationMyeloablative AgonistsTaxoidsLymphoma, FollicularBiotransformationCarcinoma, Small CellAntilymphocyte SerumInjections, IntravenousNeoplasm TransplantationLymphomaLeukapheresisAmifostineNephrotic SyndromeMice, Inbred StrainsVasculitis